Sarah Walsh

Sarah has represented:

• A multinational pharmaceutical company in internal investigations involving allegations of potential FCPA violations in multiple jurisdictions including Iraq, Pakistan, and Turkey
• A second multinational pharmaceutical company in internal investigations in Japan and Thailand
• A multinational technology company in an internal investigation resulting in recommendations to implement further procedures
• An investment advisor in an SEC investigation of potential misrepresentations and registration violations as well as DOJ and OFAC investigations
• An individual in connection with an SEC investigation of the individual’s former employer
• A real estate developer in connection with a DOJ Antitrust Division investigation that was subsequently closed by DOJ
• A multinational medical technology company in connection with a DOJ investigation into alleged violation of the FCA, resulting in the government’s declination to intervene in the underlying qui tam action
• A FinTech company in connection with joint DOJ and FTC investigations of Payroll Protection Plan (PPP) lending practices, resulting in a favorable resolution with the FTC
• A venture capital firm in connection with an OFAC investigation into potential violations of economic sanctions designations resulting in a no action letter
• A multinational semiconductor company in developing and revising corporate compliance policies and procedures
• A commodities company in training employees on compliance policies and procedures